Literature DB >> 21360204

Mutation deep within an intron of MSH2 causes Lynch syndrome.

Mark Clendenning1, Daniel D Buchanan, Michael D Walsh, Belinda Nagler, Christophe Rosty, Bryony Thompson, Amanda B Spurdle, John L Hopper, Mark A Jenkins, Joanne P Young.   

Abstract

Lynch syndrome, a heritable form of cancer predisposition, is caused by germline mutations within genes of the DNA mismatch repair family, and can be rapidly identified in young onset cancer patients through the detection of loss of expression of at least one of these genes in tumour samples. To date, such causative mutations have only been identified within exonic and splice site regions. Though this approach has been successful in the majority of families, a considerable number remain in which no mutation has been found. To address this situation, we used an alternative mutation discovery procedure which involved haplotype analysis of the locus containing the gene lost in the tumour and delineation of segregating haplotypes, followed by an investigation of splicing aberrations to uncover cryptic splice sites which lay outside the genomic regions routinely examined for mutations. In this report, we show that an intronic mutation 478 bp upstream of exon 2 in the MSH2 gene causes Lynch syndrome through creation of a novel splice donor site with subsequent pseudoexon activation, thus highlighting the need for more extensive sequencing approaches in families where routine procedures fail to find a mutation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360204      PMCID: PMC4580736          DOI: 10.1007/s10689-011-9427-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  12 in total

1.  Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.

Authors:  Andrea Mann; Estrid Hogdall; Susan J Ramus; Richard A DiCioccio; Claus Hogdall; Lydia Quaye; Valerie McGuire; Alice S Whittemore; Mitul Shah; David Greenberg; Douglas F Easton; Bruce A J Ponder; Susanne Krüger Kjaer; Simon A Gayther; Deborah J Thompson; Paul D P Pharoah; Honglin Song
Journal:  Eur J Cancer       Date:  2008-08-22       Impact factor: 9.162

2.  Origins and prevalence of the American Founder Mutation of MSH2.

Authors:  Mark Clendenning; Mark E Baze; Shuying Sun; Kyle Walsh; Sandya Liyanarachchi; Dan Fix; Victoria Schunemann; Ilene Comeras; Molly Deacon; Jane F Lynch; Gordon Gong; Brittany C Thomas; Stephen N Thibodeau; Henry T Lynch; Heather Hampel; Albert de la Chapelle
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

3.  Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.

Authors:  Michael D Walsh; Daniel D Buchanan; Margaret C Cummings; Sally-Ann Pearson; Sven T Arnold; Mark Clendenning; Rhiannon Walters; Diane M McKeone; Amanda B Spurdle; John L Hopper; Mark A Jenkins; Kerry D Phillips; Graeme K Suthers; Jill George; Jack Goldblatt; Amanda Muir; Kathy Tucker; Elise Pelzer; Michael R Gattas; Sonja Woodall; Susan Parry; Finlay A Macrae; Robert W Haile; John A Baron; John D Potter; Loic Le Marchand; Bharati Bapat; Stephen N Thibodeau; Noralane M Lindor; Michael A McGuckin; Joanne P Young
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

8.  Clonal transformation of adult human leukocytes by Epstein-Barr virus.

Authors:  B Sugden; W Mark
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

9.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Tsun Leung Chan; Monique Goossens; Konnie M Hebeda; Marsha Voorendt; Tracy Y H Lee; Danielle Bodmer; Eveline Hoenselaar; Sandra J B Hendriks-Cornelissen; Wai Yin Tsui; Chi Kwan Kong; Han G Brunner; Ad Geurts van Kessel; Siu Tsan Yuen; J Han J M van Krieken; Suet Yi Leung; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

10.  Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.

Authors:  Clemens Schafmayer; Stephan Buch; Jan Hendrik Egberts; Andre Franke; Mario Brosch; Abdou El Sharawy; Mareike Conring; Maralde Koschnick; Sven Schwiedernoch; Alexander Katalinic; Bernd Kremer; Ulrich R Fölsch; Michael Krawczak; Fred Fändrich; Stefan Schreiber; Jürgen Tepel; Jochen Hampe
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

View more
  26 in total

1.  Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.

Authors:  Sandro Rossetti; Katharina Hopp; Robert A Sikkink; Jamie L Sundsbak; Yean Kit Lee; Vickie Kubly; Bruce W Eckloff; Christopher J Ward; Christopher G Winearls; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

2.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.

Authors:  Aung Ko Win; Daniel D Buchanan; Christophe Rosty; Robert J MacInnis; James G Dowty; Gillian S Dite; Graham G Giles; Melissa C Southey; Joanne P Young; Mark Clendenning; Michael D Walsh; Rhiannon J Walters; Alex Boussioutas; Thomas C Smyrk; Stephen N Thibodeau; John A Baron; John D Potter; Polly A Newcomb; Loïc Le Marchand; Robert W Haile; Steven Gallinger; Noralane M Lindor; John L Hopper; Dennis J Ahnen; Mark A Jenkins
Journal:  Gut       Date:  2014-03-10       Impact factor: 23.059

3.  Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

Authors:  Mark A Jenkins; Aung Ko Win; Allyson S Templeton; Maggie S Angelakos; Daniel D Buchanan; Michelle Cotterchio; Jane C Figueiredo; Stephen N Thibodeau; John A Baron; John D Potter; John L Hopper; Graham Casey; Steven Gallinger; Loic Le Marchand; Noralane M Lindor; Polly A Newcomb; Robert W Haile
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

4.  Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics.

Authors:  Monika Morak; Verena Steinke-Lange; Trisari Massdorf; Anna Benet-Pages; Melanie Locher; Andreas Laner; Katrin Kayser; Stefan Aretz; Elke Holinski-Feder
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

Review 5.  Deep intronic mutations and human disease.

Authors:  Rita Vaz-Drago; Noélia Custódio; Maria Carmo-Fonseca
Journal:  Hum Genet       Date:  2017-05-12       Impact factor: 4.132

6.  ROBO1 deletion as a novel germline alteration in breast and colorectal cancer patients.

Authors:  Rolando A R Villacis; Francine B Abreu; Priscila M Miranda; Maria A C Domingues; Dirce M Carraro; Erika M M Santos; Victor P Andrade; Benedito M Rossi; Maria I Achatz; Silvia R Rogatto
Journal:  Tumour Biol       Date:  2015-10-01

7.  Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression.

Authors:  M Clendenning; F A Macrae; M D Walsh; R J Walters; S N Thibodeau; S R Gunawardena; J D Potter; R W Haile; S Gallinger; J L Hopper; M A Jenkins; C Rosty; J P Young; D D Buchanan
Journal:  Clin Genet       Date:  2012-09-27       Impact factor: 4.438

8.  Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Authors:  Daniel D Buchanan; Yen Y Tan; Michael D Walsh; Mark Clendenning; Alexander M Metcalf; Kaltin Ferguson; Sven T Arnold; Bryony A Thompson; Felicity A Lose; Michael T Parsons; Rhiannon J Walters; Sally-Ann Pearson; Margaret Cummings; Martin K Oehler; Penelope B Blomfield; Michael A Quinn; Judy A Kirk; Colin J Stewart; Andreas Obermair; Joanne P Young; Penelope M Webb; Amanda B Spurdle
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

9.  Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?

Authors:  Mark Clendenning; Michael D Walsh; Judith Balmana Gelpi; Stephen N Thibodeau; Noralane Lindor; John D Potter; Polly Newcomb; Loic LeMarchand; Robert Haile; Steve Gallinger; John L Hopper; Mark A Jenkins; Christophe Rosty; Joanne P Young; Daniel D Buchanan
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

10.  Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registry.

Authors:  Darlene Veruttipong; Amr S Soliman; Samuel F Gilbert; Taylor S Blachley; Ahmed Hablas; Mohamed Ramadan; Laura S Rozek; Ibrahim A Seifeldin
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.